Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
VanEck focuses on a clutch of biotech leaders with lower fees; Invesco tracks a select group of pharma companies with higher dividend yield and stronger five-year returns.
Barclays has gained 34.2% over the past year as core growth and stronger earnings support momentum, while elevated costs and regulatory demands pose risks.
Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its “Baron Financials ETF”. A letter can be downloaded here. In the quarter ended June 30, 2026, Baron Financials ETF (the Fund) increased by 1.82%, underperforming both the MSCI USA Financials Index (up 8.93%) and the FactSet Global FinTech Index (up 6.14%). […]
Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its “Baron Financials ETF”. A letter can be downloaded here. In the quarter ended June 30, 2026, Baron Financials ETF (the Fund) increased by 1.82%, underperforming both the MSCI USA Financials Index (up 8.93%) and the FactSet Global FinTech Index (up 6.14%). […]
Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its “Baron Financials ETF”. A letter can be downloaded here. In the quarter ended June 30, 2026, Baron Financials ETF (the Fund) increased by 1.82%, underperforming both the MSCI USA Financials Index (up 8.93%) and the FactSet Global FinTech Index (up 6.14%). […]
TRU stock gains 18.3% in three months as AI usage, OneTru innovation and strong cash flow support growth, though debt and competition pose risks.
Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its “Baron Financials ETF”. A letter can be downloaded here. In the quarter ended June 30, 2026, Baron Financials ETF™ (the Fund) increased by 1.82%, underperforming both the MSCI USA Financials Index (up 8.93%) and the FactSet Global FinTech Index (up 6.14%). […]
Pairing VOO with QQQM gives you two top performers. But is it the best idea from a portfolio construction standpoint?
Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its “Baron Financials ETF”. A letter can be downloaded here. In the quarter ended June 30, 2026, Baron Financials ETF™ (the Fund) increased by 1.82%, underperforming both the MSCI USA Financials Index (up 8.93%) and the FactSet Global FinTech Index (up 6.14%). […]
MercadoLibre's 14% three-month rally reflects ecosystem strength, but margin pressure and premium valuation temper near-term upside.
Whether you see them or not, energy businesses play a crucial part in our daily activities, from powering our homes and businesses to powering our transportation and industries.But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates and commodity prices), and the industry has underperformed the market over the past six months as its 6.7% return lagged the S&P 500 by 4.9 percentage points.
GDS jumps 13% in a month as AI-led bookings, rising utilization and a heavily pre-committed expansion pipeline support growth.
SentinelOne (NYSE:S) delivered a revenue beat and a record operating margin, yet a trimmed full-year profit outlook is what investors focused on Friday morning. The reaction pulled the broader cybersecurity group lower even as the S&P 500 held steady, a rare split between a specific-name catalyst and the broad market. SentinelOne stock is down 8% […]
With the S&P 500 on an incredible run, investors need to be clearheaded about the current market environment.
Voss Capital, LLC, an investment management company, released its second-quarter 2026 investor letter. The letter can be downloaded here. Voss Capital’s funds, Voss Value Fund, LP, and the Voss Value Offshore Fund, Ltd returned +22.4% and +23.2%, respectively, to investors net of fees and expenses, in the second quarter compared to a +21.5% return for […]
ALNT, TRVG and LQDT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 28th, 2026.
Investors will be hanging on just about every word Federal Reserve Chairman Kevin Warsh has to offer today on inflation and interest rates at the Fed’s annual conference in Jackson Hole, Wyo. Warsh might break from his predecessors on this approach, given his preference that the Fed communicate less. In recent years, stock performance has been all over the map on Jackson Hole days.
Supplies of memory chips aren't expected to catch up with demand for at least another year and a half.
A nearly $640 million writedown just sent IREN tumbling despite its AI Cloud business more than doubling, and the question now is whether today's selloff reflects a company in crisis or one eating a painful but necessary transition cost.
Even if they go mostly unnoticed, energy businesses are the backbone of our country, providing the energy we need to power our lives and businesses.Still, their generally high capital requirements expose them to the ups and downs of commodity prices and economic cycles, and the industry’s six-month return of 6.7% has fallen short of the S&P 500’s 11.6% rise.
Futures wavered while Treasury yields rose before Fed chief Kevin Warsh's Jackson Hole speech. Marvell, Affirm, PayPal are big movers.
September historically crushes stock portfolios, and with hedge funds building the largest Nasdaq short position ever recorded, retirees depending on a bull market for income face a shrinking window to reposition into safety.
The speech gives Warsha chance make up for his July 29 news conference that sent long-term Treasury yields jumping amid doubts about his determination to rein in inflation. S&P 500 futures are slightly lower and the 10-year Treasury yield modestly higher ahead of the big speech. The developments since July 29 have only raised the stakes for Warsh's talk.
The benchmark US stock measures were mostly tracking in the red before the open Friday as traders aw
ILMN's sequencing growth, oncology momentum and multiomics expansion support its outlook, though cost volatility may pressure margins.
TFX's Vascular growth, Interventional expansion and improved leverage support its outlook, while currency volatility remains a key risk.
Nasdaq 100 futures fell 0.3% while Dow futures edged higher as investors awaited Warsh's first major address as Fed chair
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
